ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 48 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $16,000 | +23.1% | 16,246 | +40.0% | 0.00% | – |
| Q2 2021 | $13,000 | -71.1% | 11,608 | -81.9% | 0.00% | – |
| Q3 2019 | $45,000 | -27.4% | 64,150 | +34.6% | 0.00% | – |
| Q2 2019 | $62,000 | -36.1% | 47,650 | +3.3% | 0.00% | – |
| Q1 2019 | $97,000 | -13.4% | 46,150 | -6.9% | 0.00% | – |
| Q4 2018 | $112,000 | +0.9% | 49,596 | +56.5% | 0.00% | – |
| Q3 2018 | $111,000 | +136.2% | 31,696 | +194.8% | 0.00% | – |
| Q4 2017 | $47,000 | -44.0% | 10,750 | -33.2% | 0.00% | – |
| Q3 2017 | $84,000 | +50.0% | 16,100 | +49.8% | 0.00% | – |
| Q2 2017 | $56,000 | -92.8% | 10,750 | -94.1% | 0.00% | -100.0% |
| Q1 2017 | $773,000 | +43.7% | 181,913 | +6.5% | 0.00% | +100.0% |
| Q4 2016 | $538,000 | +44.2% | 170,882 | +57.3% | 0.00% | 0.0% |
| Q3 2016 | $373,000 | +48.0% | 108,647 | +164.6% | 0.00% | 0.0% |
| Q1 2016 | $252,000 | -14.9% | 41,054 | -25.0% | 0.00% | 0.0% |
| Q4 2015 | $296,000 | +45.1% | 54,759 | +5.8% | 0.00% | 0.0% |
| Q1 2015 | $204,000 | – | 51,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|